Skip to main content
. 2016 May 9;7(6):901–907. doi: 10.1111/jdi.12524

Table 4.

Odds ratio of having metabolic syndrome or abnormal values for the components of metabolic syndrome according to the cardiac risk score

Cardiac risk score (0–19) Cardiac risk score (20–29) Cardiac risk score (≥30) P for trend
Metabolic syndrome Model 1 1 2.07 (1.59–2.69) 2.83 (1.93–4.15) <0.0001
Model 2 1 1.48 (1.11–1.99) 1.50 (0.97–2.32) 0.0117
Model 3 1 1.47 (1.09–1.96) 1.51 (0.98–2.34) 0.0124
Waist circumference (cm) Model 1 1 2.59 (1.91–3.52) 4.29 (2.57–7.15) <0.0001
Model 2 1 1.43 (0.98–2.09) 1.34 (0.72–2.50) 0.1
Model 3 1 1.38 (0.94–2.02) 1.32 (0.70–2.47) 0.1384
HDL‐C (mmol/L) Model 1 1 1.07 (0.79–1.46) 1.45 (0.97–2.17) 0.1015
Model 2 1 0.91 (0.66–1.26) 1.00 (0.64–1.57) 0.8594
Model 3 1 0.91 (0.66–1.25) 0.98 (0.63–1.54) 0.7903
FPG (mmol/L) Model 1 1 1.76 (1.35–2.29) 1.98 (1.37–2.85) <0.0001
Model 2 1 1.57 (1.18–2.07) 1.62 (1.08–2.43) 0.0024
Model 3 1 1.57 (1.18–2.07) 1.64 (1.10–2.46) 0.0021
Triglycerides (mmol/L) Model 1 1 1.35 (1.04–1.75) 1.56 (1.08–2.24) 0.0048
Model 2 1 1.01 (0.76–1.34) 0.93 (0.61–1.40) 0.7936
Model 3 1 0.98 (0.74–1.31) 0.93 (0.61–1.41) 0.7453
Hypertension (mmHg) Model 1 1 1.39 (1.07–1.81) 1.94 (1.31–2.86) 0.0002
Model 2 1 1.18 (0.89–1.57) 1.49 (0.97–2.28) 0.0581
Model 3 1 1.18 (0.89–1.56) 1.51 (0.98–2.32) 0.0524

Data are odds ratios (95% confidence interval) compared with cardiac risk score (0–19) group. Participants with abnormal values for Waist circumference, high‐density lipoprotein cholesterol (HDL‐C), fasting plasma glucose (FPG), triglycerides and hypertension (as defined in the metabolic syndrome) are defined as 0, and with normal values as 1. Participants without metabolic syndrome are defined as 0 and with metabolic syndrome as 1. Model 1 is unadjusted. Model 2 is adjusted for sex and body mass index. Model 3 is adjusted for sex, body mass index, current smoking and current drinking.